Hofseth BioCare ASA (OSL:HBC)

Hofseth BioCare ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	107.98	67.05	25.58	23.89	32.43	49.92
Cash & Short-Term Investments	107.98	67.05	25.58	23.89	32.43	49.92
Cash Growth	58.70%	162.15%	7.06%	-26.33%	-35.04%	-71.12%
Accounts Receivable	30.42	21.52	18.85	14.85	14.07	10.09
Other Receivables	-	5.62	5.9	4.92	6.84	13.37
Receivables	30.42	27.14	24.76	19.76	20.91	23.46
Inventory	54.37	59.83	55.92	82.54	116.53	90.81
Prepaid Expenses	-	5.34	4.59	2.55	1.51	1.61
Other Current Assets	11.43	2.43	1.23	2.26	4.38	4.51
Total Current Assets	204.19	161.79	112.06	131	175.75	170.31
Property, Plant & Equipment	143.31	146.93	137.98	165.7	168.79	185.83
Long-Term Investments	44.49	47.85	45.7	37.69	5.56	5.76
Other Intangible Assets	33.4	3.2	3.98	5.43	6.46	53.06
Long-Term Deferred Charges	-	33.3	38.45	49.85	54.13	-
Other Long-Term Assets	1.19	1.2	1.25	0.44	0.34	1.01
Total Assets	426.59	394.27	339.42	390.12	411.03	415.97

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	104.99	94.62	93.63	55.16	145.75	124.17
Accrued Expenses	-	15.25	15.56	13.03	13.08	12.25
Short-Term Debt	-	115.69	47.75	172.35	-	-
Current Portion of Long-Term Debt	121.5	-	0.27	0.54	0.54	2.42
Current Portion of Leases	-	15.66	11.22	10.79	12.86	12.1
Other Current Liabilities	14.41	0	0	-	-	-
Total Current Liabilities	240.89	241.22	168.42	251.88	172.23	150.93
Long-Term Debt	217.1	139	25.1	0.27	0.81	23.79
Long-Term Leases	-	89.59	86.54	96.83	89.96	100.88
Other Long-Term Liabilities	-0	0	-	-	-	-0
Total Liabilities	457.99	469.81	280.07	348.98	263	275.6

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.11	4.11	4.11	3.95	3.95	3.58
Additional Paid-In Capital	-	-	55.93	37.88	144.77	137.49
Comprehensive Income & Other	-34.83	-78.96	-0	-	-	-
Total Common Equity	-30.72	-74.84	60.04	41.83	148.72	141.06
Minority Interest	-0.69	-0.69	-0.69	-0.69	-0.69	-0.69
Shareholders' Equity	-31.41	-75.53	59.36	41.14	148.03	140.38
Total Liabilities & Equity	426.59	394.27	339.42	390.12	411.03	415.97

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	338.6	359.94	170.88	280.79	104.17	139.18
Net Cash (Debt)	-230.62	-292.89	-145.3	-256.9	-71.74	-89.26
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.56	-0.71	-0.35	-0.65	-0.19	-0.25
Filing Date Shares Outstanding	522.24	411.08	411.08	395.08	395.08	357.83
Total Common Shares Outstanding	522.24	411.08	411.08	395.08	395.08	357.83
Working Capital	-36.7	-79.42	-56.36	-120.87	3.52	19.38
Book Value Per Share	-0.06	-0.18	0.15	0.11	0.38	0.39
Tangible Book Value	-64.12	-78.05	56.06	36.39	142.25	88.01
Tangible Book Value Per Share	-0.12	-0.19	0.14	0.09	0.36	0.25
Machinery	-	234.67	-	212.49	204.3	199.52

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error